4771
410
Loading version...
🔄 Update App
🔍 Check for Updates
Test Notification
🔔 Enable Notifications
📰 Fetch NHK News
🚀 Fetch TechCrunch News
🧪 Experiment
📰 Article Management
📚 Reading List
🎤 Speaking List
📊 Statistics
💻 Software Statistics
Push Admin
Edit Reading
Back to List
Basic Information
Title
Please enter a title.
URL
Please enter a valid URL.
Date
カテゴリID
画像ファイル名
統計情報
単語数:
118語
読了回数:
0回
作成日:
2022/01/26 10:21
更新日:
2025/12/09 18:07
本文
本文
Scientists saw the coronavirus Omicron variant sweep across the world at a pace that was unprecedented. On Tuesday, drugmakers Pfizer and BioNTech announced a clinical trial of a vaccine adapted to target the strain. The scientists will enroll more than 1400 adults ages 18 to 55. They will evaluate how the vaccine performs in people who have already received two or three doses. They will also test the shots in those who have not been vaccinated. Officials at the World Health Organization have said the current Pfizer vaccine protects people exposed to Omicron from severe disease and hospitalization. Executives at the US pharmaceutical company said, over time, those protections could fade. They said they need to be prepared.
本文を入力してください。
メモ
メモ・感想
キャンセル
更新
Debug Info:
Saved State:
-
Redirected Flag:
-
Current URL:
-
Refresh
Close
Debug
Send Report
Send Report
Draw Arrow
Clear
Message:
Cancel
Send
